Analysts estimate that Albertsons Companies will report an earnings per share (EPS) of $0.52. Investors in Albertsons ...

The announcement from Wells Fargo is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The big-bank earnings reports due this week mark the quasi-official start to the second-quarter earnings season. Analysts ...

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

Irvine, California-based Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced ...

Pfizer (PFE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.

Pfizer's cost-cutting boosts earnings despite revenue miss. Discover its growth strategy, strong drug portfolio & potential 29% upside. Click here to read.